Advertisement

Improving Outcomes in Sepsis and Septic Shock: Getting it Right the First Time

  • Duane Funk
  • Shravan Kethireddy
  • Anand KumarEmail author
Chapter

Abstract

Infections among critically ill patients have convincingly been shown to directly increase mortality, prolong hospital length of stays, and increase healthcare costs (Chastre and Fagon 2002; Rello et al. 2002). In the past the general approach to antimicrobial therapy of infection involved an escalation strategy wherein patients were started on the narrowest reasonable antimicrobial regimen expected to cover a majority of common pathogens. In addition to mild and moderately ill patients, this strategy was also applied to the critically ill at high risk of death.

Keywords

Septic Shock Antimicrobial Therapy Minimum Inhibitory Concentration Inappropriate Therapy Baseline Mortality 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Alvarez-Lerma F, ICU-acquired Pneumonia Study Group (1996) Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. Intensive Care Med 22:387–394PubMedCrossRefGoogle Scholar
  2. Ammerlaan H, Seifert H et al (2009) Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries. Clin Infect Dis 49:997–1005PubMedCrossRefGoogle Scholar
  3. Bantar C, Alcazar G et al (2007) Are laboratory based antibiograms reliable to guide the selection of empirical antimicrobial treatment in patients with hospital acquired infections? J Antimicrob Chemother 59:140–143PubMedCrossRefGoogle Scholar
  4. Bare M, Castells X et al (2006) Importance of appropriateness of empiric antibiotic therapy on clinical outcomes in intraabdominal infections. Int J Technol Assess Health Care 22:242–248PubMedCrossRefGoogle Scholar
  5. Byl B, Clevenbergh P et al (1999) Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. Clin Infect Dis 29:60–66PubMedCrossRefGoogle Scholar
  6. Chastre J, Fagon JY (2002) Ventilatory-associated pneumonia. Am J Respir Crit Care Med 265:867–903Google Scholar
  7. Cheng AC, Buising KL (2009) Delayed administration of antibiotics and mortality in patients with community acquired pneumonia. Ann Emerg Med 53(5):618–624PubMedCrossRefGoogle Scholar
  8. Depuydt PO, Vandijck DM et al (2008) Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated-pneumonia. Crit Care Med 12(6)Google Scholar
  9. Falagas ME, Barefoot L et al (1996) Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections. Eur J Clin Microbiol Infect Dis 15(12):913–921PubMedCrossRefGoogle Scholar
  10. Fowler VG, Sanders LL et al (1998) Outcome of staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 27:478–486PubMedCrossRefGoogle Scholar
  11. Franson TR, Quebbeman EJ et al (1988) Prospective comparison of traditional and pharmacokinetic aminoglycoside dosing methods. Crit Care Med 16(9):840–843PubMedCrossRefGoogle Scholar
  12. Gacouin A, Le Tulzo Y et al (2002) Severe pneumonia due to Legionella pneumophila: prognostic factors, impact of delayed appropriate antimicrobial therapy. Intensive Care Med 28(6):686–691PubMedCrossRefGoogle Scholar
  13. Gaieski DF, Mikkelsen ME et al (2010) Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med 38(4):1045–1053PubMedCrossRefGoogle Scholar
  14. Garey KW, Rege M et al (2006) Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 43:25–31PubMedCrossRefGoogle Scholar
  15. Garnacho-Montero J, Garcia-Garmendia JL et al (2003) Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med 31(12):2742–2751PubMedCrossRefGoogle Scholar
  16. Harbarth S, Garbino J et al (2003) Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 115:529–535PubMedCrossRefGoogle Scholar
  17. Hindler JF, Stelling J (2007) Analysis and presentation of cumulative antibiograms: a new consensus guideline from the Clinical and Laboratory Standards Institute. Clin Infect Dis 44(6):867–873PubMedCrossRefGoogle Scholar
  18. Houck PM, Bratzler DW et al (2004) Timing of antibiotic administration and outcomes for medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 164:637–644PubMedCrossRefGoogle Scholar
  19. Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Bilker WB, Lautenbach E. Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection. Arch Intern Med. 2005 Jun 27;165(12):1375–80PubMedCrossRefGoogle Scholar
  20. Ibrahim EH, Sherman G et al (2000) The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118(1):146–155PubMedCrossRefGoogle Scholar
  21. Kaufman D, Haas CE et al (1998) Antibiotic Susceptibility in the surgical Intensive care unit compared with the hospital wide antibiogram. Arch Surg 133:1041–1045PubMedCrossRefGoogle Scholar
  22. Kim SH, Park WB et al (2009) You only find what you look for: the importance of high creatinine clearance in the critically ill. Anaesth Intensive Care 37(1):11–13Google Scholar
  23. Kollef MH (2000) Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 31(Suppl 4):S131–S138PubMedCrossRefGoogle Scholar
  24. Kollef MH, Sherman G et al (1999) Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115(2):462–474PubMedCrossRefGoogle Scholar
  25. Kreger BE, Craven DE et al (1980) Gram negative bacteremia IV. Reevaluation of clinical features and treatment in 612 patients. Am J Med 68:344–355PubMedCrossRefGoogle Scholar
  26. Krobot K, Yin D et al (2004) Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intrabdominal infections requiring surgery. Eur J Clin Microbiol Infect Dis 23:682–687PubMedCrossRefGoogle Scholar
  27. Kumar A, Roberts D et al (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589–1596PubMedCrossRefGoogle Scholar
  28. Kumar A, Ellis P et al (2009) Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 136:1237–1248PubMedCrossRefGoogle Scholar
  29. Kumar A, Safdar N et al (2010) The survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent on the risk of death: a meta-analytic/meta-regression study. Crit Care Med 38(8):1651–1664PubMedCrossRefGoogle Scholar
  30. Leibovici L, Paul M et al (1997) Monotherapy versus beta-lactam aminoglycoside combination treatment for gram negative bacteremia: a prospective, observational study. Antimicrob Agents Chemother 41:1127–1133; (erratum appears in AAC 1997 Nov;41(11):2595)PubMedGoogle Scholar
  31. Leibovici L, Shraga I et al (1998) The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 244:379–386PubMedCrossRefGoogle Scholar
  32. Leroy O, Saux P et al (2005) Comparison of levofloxacin and cefotaxime combined with ofloxacin for ICU patients with community-acquired pneumonia: a retrospective study and meta-analysis. Chest 128:172–183PubMedCrossRefGoogle Scholar
  33. Lodise TP, Patel N et al (2007) Predictors of 30-day mortality among patients with pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection. Antimicrob Agents Chemother 51(10):3510–3515PubMedCrossRefGoogle Scholar
  34. Mandell LA, Wunderink RG et al (2007) Infectious Disease Society of America/American Thoracic Society guidelines on management of community acquired pneumonia in adults. Clin Infect Dis 44:S27–S72PubMedCrossRefGoogle Scholar
  35. Mccabe WR, Jackson GG (1962) Gram negative bacteremia II. Clinical, laboratory, and therapeutic observations. Arch Intern Med 110:856–864Google Scholar
  36. McGregor JC, Rich SE et al (2007) A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients. Clin Infect Dis 45:329–337PubMedCrossRefGoogle Scholar
  37. Meehan TP, Fine MJ et al (1997) Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 278(23):2080–2084PubMedCrossRefGoogle Scholar
  38. Micek ST, Kollef KE et al (2007) Health care-associated pneumonia and community -acquired pneumonia: a single center experience. Antimicrob Agents Chemother 51(10):3568–3573PubMedCrossRefGoogle Scholar
  39. Micek ST, Welch EC et al (2010) Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis. Antimicrob Agents Chemother 54(5):1742–1748PubMedCrossRefGoogle Scholar
  40. Moellering RC (2009) What is inadequate antibacterial therapy. Clin Infect Dis 49:1006–1008PubMedCrossRefGoogle Scholar
  41. Moise PA, Forrest A et al (2004) Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. Clin Pharmacokinet 43:925–942CrossRefGoogle Scholar
  42. Morrell M, Fraser VJ et al (2005) Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 49:3640–3645PubMedCrossRefGoogle Scholar
  43. Niederman MS, Craven DE et al (2005) Guidelines for the management of adults with hospital acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171:388–416CrossRefGoogle Scholar
  44. Parkins MD, Sabuda DM et al (2007) Adequacy of empiric antifungal therapy and effect on outcome among patients with invasive Candida species infections. J Antimicrob Chemother 60:613–618PubMedCrossRefGoogle Scholar
  45. Patel GP, Simon D et al (2009) The effect of time to antifungal therapy on mortality in Candidemia associated septic shock. Am J Ther 16(6):508–511PubMedCrossRefGoogle Scholar
  46. Peralta G, Sanchez MB, Garrido JC, De Benito I, Cano ME, Martinez-Martinez L, Roiz MP. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia. J Antimicrob Chemother. 2007 Oct;60(4):855–63PubMedCrossRefGoogle Scholar
  47. Raineri E, Pan A et al (2008) Role of the infectious diseases specialist consultant on the appropriateness of antimicrobial therapy prescription in an intensive care unit. Am J Infect Control 36:283–290PubMedCrossRefGoogle Scholar
  48. Rello J, Ollendorf DA et al (2002) Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 122:2121Google Scholar
  49. Rivers E, Nguyen B et al (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345(19):1368–1377PubMedCrossRefGoogle Scholar
  50. Roberts JA, Lipman J (2006) Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis. Clin Pharmacokinet 45(8):755–773PubMedCrossRefGoogle Scholar
  51. Rotstein C, Evans G et al (2008) AMMI Canada guidelines-clinical practice guidelines for hospital acquired pneumonia and ventilator-associated pneumonia in adults. Can J Infect Dis Med Microbiol 19:19–53PubMedGoogle Scholar
  52. Sitges-Serra A, Lopez MJ et al (2002) Postoperative enterococcal infection after treatment of complicated intra-abdominal sepsis. Br J Surg 89:361–367PubMedCrossRefGoogle Scholar
  53. Sturkenboom MCJM, Goettsch WG et al (2005) Inappropriate initial treatment of secondary intraabdominal infections leads to increased risk of clinical failure and costs. Br J Clin Pharmacol 60:438–443PubMedCrossRefGoogle Scholar
  54. Tellado JM, Sen SS et al (2007a) Consequences of inappropriate initial empiric parenteral antibiotic therapy among patients with community acquired intraabdominal infections in Spain. Scand J Infect Dis 39:947–955PubMedCrossRefGoogle Scholar
  55. Tellado JM, Sen SS et al (2007b) Consequences of inappropriate initial empiric parenteral antibiotic therapy among patients with community-acquired intra-abdominal infections in Spain. Scand J Infect Dis 39(11–12):947–955PubMedCrossRefGoogle Scholar
  56. Tumbarello M, Sali M, Trecarichi EM, Leone F, Rossi M, Fiori B, De Pascale G, D’Inzeo T, Sanguinetti M, Fadda G, Cauda R, Spanu T. Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. Antimicrob Agents Chemother. 2008 Sep;52(9):3244–52PubMedCrossRefGoogle Scholar
  57. Udy A, Roberts JA et al (2009) You only find what you look for: the importance of high creatinine clearance in the critically ill. Anaesth Intensive Care 37(1):11–13PubMedGoogle Scholar
  58. Valles J, Rello J et al (2003) Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. Chest 123(5):1615–1624PubMedCrossRefGoogle Scholar
  59. Whipple JK, Ausman RK et al (1991) Effect of individualized pharmacokinetic dosing on patient outcome. Crit Care Med 19(12):1480–1485PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  1. 1.Section of Critical Care MedicineUniversity of ManitobaWinnipegCanada
  2. 2.Section of Critical Care Medicine, Section of Infectious DiseasesUniversity of ManitobaWinnipegCanada
  3. 3.Section of Critical Care Medicine, JJ399dHealth Sciences CentreWinnipegCanada
  4. 4.Robert Wood Johnson Medical SchoolUniversity of Medicine and DentistryPiscatawayUSA

Personalised recommendations